olmutinib,
Olmutinib,
1353550-13-6,
HM61713,
BI 1482694,
HM71224,
UNII-CHL9B67L95,
HM-61713,
CHL9B67L95,
1802181-20-9,
Olmutinib (HM61713, BI 1482694),
N-(3-((2-((4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)phenyl)acrylamide,
N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide,
Olmutinib [INN],
2-Propenamide, N-(3-((2-((4-(4-methyl-1-piperazinyl)phenyl)amino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)-,
2-Propenamide, N-[3-[[2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]-,
Olmutinib [WHO-DD],
HM71224;Olmutinib,
Olmutinib (USAN/INN),
Olmutinib [USAN:INN],
Olmutinib(HM-71224),
HM-61713 (BI-1482694),
GTPL9196,
CHEMBL3786343,
SCHEMBL14914931,
EX-A879,
FDMQDKQUTRLUBU-UHFFFAOYSA-N,
BCP16733,
BDBM50160871,
MFCD29918158,
s8294,
olmutinib-hm61713-bi-1482694,
AKOS030632791,
ZINC198970879,
CS-5413,
DB13164,
SB19797,
Example 1 [US20130116213],
AC-30225,
AK547268,
HM 71224,
HY-19730,
BI1482694,
BI-1482694,
FT-0700176,
J3.435.413H,
D10859,
J-690142,
4-{[4-({[(1R,2S)-2-Phenylcyclopropyl]amino}methyl)-1-piperidinyl]methyl}benzoic acid,
N-(3-((2-(4-(4-Methylpiperazin-1-yl)anilino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)prop-2-enamide,
N-(3-(2-(4-(4 methylpiperazin-1-yl)phenylamino)thieno[3,2-d]pyrimidine-4-yloxy)phenyl)acrylamide,
N-(3-(2-(4-(4-methylpiperazin-1-yl)phenylamino)thieno[3,2-d]pyrimidine-4-yloxy)phenyl)acrylamide,
N-[3-[[2-[[4-(4-Methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]-2-pro,
N-{3-[(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}thieno[3,2-d]pyrimidin-4-yl)oxy]phenyl}prop-2-enamide,
olita,
olmutinib HCl,
olmutinib hydrochloride,
HM 61713,
A15976,